Spire Wealth Management’s LeMaitre Vascular LMAT Stock Holding History

Spire Wealth Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$355K	Buy	+3,700	New	+$379K	0.01%	632

Other funds holding LMAT

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

Chatham Capital Group Savannah, Georgia $783M AUM 31.99% 1-Year Est. Return

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Nations Financial Group Cedar Rapids, Iowa $2.09B AUM 34.27% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Spire Wealth Management's LMAT Position: Q2 2026 in Review

Spire Wealth Management opened a new position in LeMaitre Vascular (LMAT) in Q2 2026: 3,700 shares worth $355K. The stake represents 0.01% of the portfolio and ranks #632 among its holdings.

63 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Spire Wealth Management held 3,700 shares of LeMaitre Vascular worth $355K as of Q2 2026.
LeMaitre Vascular was a new Spire Wealth Management position in Q2 2026.
LeMaitre Vascular made up 0.01% of Spire Wealth Management's portfolio in Q2 2026, its #632 holding.
63 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.